FOXP3 1 regulatory T cells (T reg cells) are abundant in the intestine, where they prevent dysregulated inflammatory responses to self and environmental stimuli. It is now appreciated that T reg cells acquire tissue-specific adaptations that facilitate their survival and function 1 ; however, key host factors controlling the T reg response in the intestine are poorly understood. The interleukin (IL)-1 family member IL-33 is constitutively expressed in epithelial cells at barrier sites 2 , where it functions as an endogenous danger signal, or alarmin, in response to tissue damage 3 . Recent studies in humans have described high levels of IL-33 in inflamed lesions of inflammatory bowel disease patients [4] [5] [6] [7] , suggesting a role for this cytokine in disease pathogenesis. In the intestine, both protective and pathological roles for IL-33 have been described in murine models of acute colitis [8] [9] [10] [11] , but its contribution to chronic inflammation remains ill defined. Here we show in mice that the IL-33 receptor ST2 is preferentially expressed on colonic T reg cells, where it promotes T reg function and adaptation to the inflammatory environment. IL-33 signalling in T cells stimulates T reg responses in several ways. First, it enhances transforming growth factor (TGF)-b 1 -mediated differentiation of T reg cells and, second, it provides a necessary signal for T reg -cell accumulation and maintenance in inflamed tissues. Strikingly, IL-23, a key pro-inflammatory cytokine in the pathogenesis of inflammatory bowel disease, restrained T reg responses through inhibition of IL-33 responsiveness. These results demonstrate a hitherto unrecognized link between an endogenous mediator of tissue damage and a major anti-inflammatory pathway, and suggest that the balance between IL-33 and IL-23 may be a key controller of intestinal immune responses.
To identify potential tissue-specific modulators of colonic T reg cells, we compared the messenger RNA expression profiles of mesenteric lymph node and colonic T reg cells. We identified St2 (also known as Il1rl1), the transcript coding for the IL-33 receptor 12 , as one of the top differentially upregulated genes in colonic T reg cells (Fig. 1a, b ). Flow-cytometric analysis confirmed selective enrichment of ST2 1 T reg cells in the colon (Fig. 1c ) and these cells expressed high levels of the activation markers KLRG1, CD103 and OX40 (Fig. 1d ). Analysis of Helios expression revealed that ST2 1 T reg cells are a heterogeneous population containing thymus-derived T reg cells as well as peripherally generated Helios 2 T reg cells (Fig. 1e) 13 . A significant proportion of intestinal Foxp3 1 T reg cells co-express the transcription factor GATA3 (refs [14] [15] [16] , and GATA3 is known to regulate ST2 expression in T H 2 cells 17 . Indeed, ST2 expression was largely restricted to GATA3-expressing colonic T reg cells ( Fig. 1e ) and selective ablation of GATA3 in Foxp3-expressing cells, using Gata3 fl/fl -Foxp3-cre mice 15 , caused a marked reduction of ST2 protein levels (Fig. 1f) .
Given that ST2 1 T reg cells are prominent in the colon, we postulated that IL-33 may modulate in vitro induced (i)T reg -cell differentiation.
To test this, we sort-purified naive CD4 1 T cells from Foxp3 gfp reporter mice and activated them in the presence of TGF-b 1 . Notably, both Gata3 and St2 expression were induced under iT reg -differentiation conditions (Extended Data Fig. 1 ). Addition of IL-33 to iT reg cultures significantly increased both the percentage and total number of Foxp3-expressing cells but had no effect on Foxp3 expression in the absence of TGF-b 1 (Fig. 2a ). The presence of IL-33 in iT reg cultures did not affect induction of T H 2 cytokines or expression of T H 1-and T H 17-associated transcription factors Tbx21 and Rorc (Extended Data Fig. 1 ), suggesting that IL-33 preferentially regulates Foxp3 expression. Thus, our data indicate *These authors contributed equally to this work. 1 that the alarmin IL-33 is a novel cofactor in TGF-b 1 -mediated iT reg generation. GATA3 is highly expressed in ST2 1 T reg cells ( Fig. 1e ) and IL-33 has been shown to activate GATA3 in T H 2 cells 17, 18 as well as in innate lymphoid cells 19 . Consistent with this notion, we observed serine phosphorylation of GATA3 upon acute stimulation of iT reg cells with IL-33 ( Fig. 2b ). The Foxp3 locus contains putative GATA3-binding sites within its promoter and intragenic conserved noncoding sequences (CNSs) 1-3 (ref. 14) . To investigate whether IL-33 influences the binding of GATA3 to any of these elements in iT reg cells, we performed chromatin immunoprecipitation (ChIP) followed by quantitative polymerase chain reaction (PCR). Acute stimulation of iT reg cells with IL-33 induced GATA3 recruitment to the Foxp3 promoter but not CNS1, 2 or 3 (Fig. 2c ). In addition, RNA polymerase II (Pol II) was recruited to the Foxp3 promoter upon IL-33 stimulation ( Fig. 2d ), suggesting that IL-33 directly regulates Foxp3 expression through activation and recruitment of GATA3 to the Foxp3 promoter. In T H 2 cells, GATA3 has been shown to promote St2 gene expression by binding to an enhancer element located 12 kilobases upstream of the St2 transcription start site 17 . Consistent with this, we detected recruitment of GATA3 to the St2 enhancer upon acute stimulation of iT reg cells with IL-33 and this correlated with RNA Pol II enrichment at the St2 promoter (Extended Data Fig. 2 ). Thus, in addition to its role in Foxp3 induction, IL-33 also promoted its own receptor expression in iT reg cells through direct transcriptional regulation of the St2 locus, providing an amplification loop for further enhancement of iT reg -cell differentiation.
Next we focused on thymus-derived T reg cells, which constitute a significant proportion of ST2 1 colonic T reg cells (Fig. 1e ). In line with published reports 20, 21 , administration of recombinant IL-33 led to a significant increase in the frequency and total number of splenic T reg cells (Extended Data Fig. 3a , b) and these IL-33-elicted T reg cells expressed higher levels of Foxp3 and ST2 (Extended Data Fig. 3c, d ). Further analysis of the proliferation marker Ki67 showed that IL-33 induced proliferation in splenic T reg cells but not in T effector cells (Extended Data Fig. 3e ). To examine whether IL-33 acts directly on T reg cells, we injected IL-33 into chimaeric mice containing a mixture of wild-type and St2 2/2 haematopoietic cells. In this setting, the proliferative capacity of St2 2/2 T reg cells was significantly impaired (Extended Data Fig. 3f ), suggesting that IL-33 acts directly on thymus-derived T reg cells to promote their proliferation and accumulation in vivo. This is further supported by the finding that sort-purified splenic T reg cells cultured in the presence of IL-33 expressed higher levels of ST2, showed a more activated phenotype and expressed increased amounts of Foxp3 protein ( Fig. 2e ). In addition, acute stimulation of T-cell antigen receptor (TCR)-activated splenic T reg cells with IL-33 induced serine phosphorylation of GATA3 ( Fig. 2f ), further demonstrating that IL-33 acts directly on thymusderived T reg cells.
To assess the impact of IL-33 on the T reg response during intestinal inflammation, we induced chronic colitis by infection with Helicobacter hepaticus and administration of an IL-10R blocking antibody 22 (Extended Data Fig. 4a ). We detected an increase in IL-33 protein levels in colon explant cultures and its expression kinetics mirrored that of IL-23, which is essential for the development of intestinal inflammation in this model (Extended Data Fig. 4b ). Consistent with its pattern of expression, IL-33 protein levels were elevated in colonic intestinal epithelial cells isolated from the inflamed gut (Extended Data Fig. 4c, d) . Interestingly, the onset of intestinal pathology correlated with a marked increase of soluble ST2, which is produced primarily by colonic stromal cells (Extended Data Fig. 4b , e, f). Soluble ST2 is thought to limit IL-33 bioavailability by acting as a decoy receptor 23 and is increased in patients with active inflammatory bowel disease (IBD) 6, 24 , suggesting that the chronic inflammatory tissue environment may antagonize IL-33 activity. Despite high levels of soluble ST2, analysis of chimaeric mice showed that accumulation of St2 2/2 T reg cells in the colon but not the spleen was significantly impaired during the peak of intestinal inflammation (Fig. 2g ). In addition, colonic CD4 1 T cells were cultured with anti-CD3/CD28 plus the indicated cytokines and the frequencies and absolute numbers of Foxp3 1 T cells were determined 3 days later (mean 6 standard error of the mean (s.e.m.) of three independent experiments). b, Naive CD4 1 T cells were cultured for 48 h with anti-CD3/ CD28 plus TGF-b 1 , followed by stimulation with IL-33 for 45 min. Blots are representative of two independent experiments. p, phosphorylated. c, d, Cells were cultured and stimulated as in b and recruitment of GATA3 or RNA Pol II to the indicated regions was assessed by ChIP-qPCR. Data are from one experiment representative of two (mean 6 standard deviation (s.d.)). Pro., promoter. 2, no IL-33 added. e, Representative plots of T reg cells cultured with anti-CD3/CD28 plus indicated cytokines and analysed after 3 days. Data are representative of three independent experiments. f, T reg cells were cultured with anti-CD3/CD28 for 24 h followed by stimulation with IL-33. Blots are representative of three independent experiments. g, Mixed chimaeras were generated containing wild-type (WT) and St2 2/2 bone marrow cells. Reconstituted mice were analysed at steady state or 2 weeks after infection with H. hepaticus and anti-IL-10R treatment (inflamed). Absolute numbers of wild-type or St2 2/2 T reg cells in steady state (n 5 3) and inflamed (n 5 6) hosts (mean 6 s.e.m.). h, Analysis of Foxp3 expression in T reg cells in spleen (SPN) and colon from inflamed chimaeric hosts presented as geometric mean fluorescence intensity (gMFI). *P , 0.05, **P , 0.01, ***P , 0.001 as calculated by one-way analysis of variance (ANOVA) with Bonferroni post-test or paired Student's t-test.
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basis as compared to their wild-type counterparts (Fig. 2h ). Together, these observations indicate that the alarmin IL-33 acts in a cell-intrinsic manner to promote the tissue-specific accumulation and stability of the T reg phenotype in the intestine under inflammatory conditions. Furthermore, high levels of soluble ST2 during chronic intestinal inflammation may represent a mechanism to further perpetuate pathogenic responses by limiting IL-33-driven T reg accumulation.
We next sought to compare the suppressive capacity of wild-type and St2 2/2 T reg cells. St2 2/2 T reg cells inhibited T-cell proliferation to the same extent as wild-type T reg cells in vitro (Extended Data Fig. 5 ) and addition of IL-33 did not enhance wild-type T reg suppressor function. We then tested the ability of St2 2/2 T reg cells to protect from colitis induced by adoptive transfer of naive CD4 1 T cells. Interestingly, ST2 was highly expressed on wild-type T reg cells upon T-cell transfer, pointing towards a potential role of ST2 in modulating T reg function in this model (Extended Data Fig. 6a ). Indeed, St2 2/2 T reg cells were significantly impaired in their ability to prevent colonic inflammation and cellular infiltration ( Fig. 3a, b ), demonstrating that IL-33 signalling in T reg cells is important for their suppressive function in vivo. Analysis of wild-type or St2 2/2 T reg cells 2 weeks after transfer, before the onset of intestinal pathology, showed similar proliferative capacity and Foxp3 expression between groups (Fig. 3c ). The ratio of T effector cells (CD45.1 1 RB hi progeny) to T reg cells (CD45.1 2 Foxp3 1 T reg progeny) was also similar ( Fig. 3d ), suggesting that IL-33 signalling in T reg cells is dispensable for their ability to expand and index with effector cells in the lymphopenic host at 2 weeks after transfer. By contrast, analysis at 8 weeks after transfer showed that the progeny of St2 2/2 T reg cells contained a significantly lower proportion of Foxp3 1 cells and expressed significantly less Foxp3 on a per cell basis, suggesting that they had lost Foxp3 expression ( Fig. 3e, h ). Under these circumstances the ratio of T effector/T reg cells and the total number of T effector cells (CD45.1 1 RB hi progeny) was markedly increased in recipients of St2 2/2 T reg cells (Fig. 3f, g) . Importantly, ST2-deficient T reg cells did not themselves acquire the capacity to produce inflammatory cytokines (Extended Data Fig. 6c ). Perturbations of Foxp3 expression have been shown to affect T reg -cell function [25] [26] [27] and our data indicate that IL-33 signalling in T reg cells contributes to the maintenance of Foxp3 expression under inflammatory stress, enabling T reg cells to compete in the inflammatory niche and to control the intestinal effector T-cell response.
Next we sought to integrate our observations with existing proinflammatory pathways. IL-23 is a pivotal mediator of intestinal inflammation and polymorphisms in the IL23R locus are associated with increased susceptibility to IBD in humans 28 . We previously showed that IL-23 promotes intestinal inflammation in part through inhibition of iT reg -cell differentiation 29, 30 . However, the mechanism by which IL-23 blocked iT reg generation remained undefined. Interestingly, whole transcriptome analysis of IL-23 target genes in colonic effector CD4 1 T cells revealed that IL-23 inhibits expression of Gata3 and St2 (Extended Data Fig. 7 ). On the basis of this observation we hypothesized that IL-23 might limit T-cell responsiveness to IL-33. Indeed, the cofactor activity of IL-33 on TGF-b 1 -mediated Foxp3 induction in vitro was completely abrogated in the presence of IL-23 (Fig. 4a) . Notably, addition of IL-23 prevented induction of Gata3 and St2 mRNA under iT reg differentiation conditions (Fig. 4b) , resulting in reduced ST2 protein expression ( Fig. 4c ). Consequently, acute stimulation of IL-23-exposed iT reg cells with IL-33 did not lead to recruitment of GATA3 to the ST2 enhancer (Extended Data Fig. 8 ). We observed a similar role for IL-23 in limiting T reg ST2 expression during bacterially driven intestinal inflammation (Extended Data Fig. 9 ). Collectively, our data indicate that IL-23 inhibits iT reg differentiation by regulating T-cell responsiveness to IL-33.
We previously showed that IL-23 restrains T reg cells in vivo because naive T-cell transfer into Il23a 2/2 Rag1 2/2 recipients resulted in increased T reg -cell differentiation 29 . Therefore, we hypothesized that enhanced responsiveness to IL-33 may contribute to increased iT reg differentiation in Il23a 2/2 Rag1 2/2 hosts. To test this, we transferred wild-type or St2 2/2 naive T cells into Il23a 2/2 Rag1 2/2 hosts and monitored iT regcell generation. Indeed, ST2-deficient T cells were significantly impaired in their ability to differentiate into T reg cells ( Fig. 4d ) and this correlated with a significant increase in intestinal pathology (Fig. 4e ). Importantly, 
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ST2 deficiency had minor effects on in vivo differentiation of T H 1, T H 2 or T H 17 cells (Fig. 4f) , further supporting the notion that the increased colitogenic potential of St2 2/2 CD4 1 T cells is a consequence of deficient iT reg differentiation rather than dysregulated effector T-cell responses. Our data strongly suggest that IL-33 is a major factor responsible for driving iT reg differentiation in the absence of IL-23.
Finally, we investigated whether IL-23 can interfere with ST2 signalling in T reg cells. Interestingly, sort-purified ST2 1 T reg cells from the colon expressed detectable levels of Il23r (Extended Data Fig. 10 ). Indeed, exposure of TCR-activated thymus-derived T reg cells to IL-23 completely abolished IL-33-mediated GATA3 phosphorylation (Fig. 4g ). Furthermore, IL-33 preferentially induced genes co-regulated by Foxp3 and GATA3 (ref. 16) , and this was completely abrogated in the presence of IL-23 ( Fig. 4h ). Addition of a specific inhibitor of STAT3, the main transcription factor downstream of IL-23 signalling, reversed this inhibitory effect of IL-23 ( Fig. 4i ). Together our data suggest that IL-23 inhibits ST2 signal transduction and expression of a distinct set of GATA3-regulated genes in thymus-derived T reg cells.
Our results identify a new function for IL-33 as an important link between inflammation-driven tissue damage and the local intestinal T regcell response. We show that colonic T reg cells are poised to respond to the release of IL-33 upon tissue damage through selective expression of ST2 and that signalling through this pathway has an essential role in their capacity to adapt to the inflammatory tissue environment and restrain intestinal inflammation. The ability of IL-33 to amplify regulatory networks in response to tissue injury may represent a more general mechanism by which alarmins limit immune-mediated damage to self at barrier tissues. Strikingly, IL-23 limits this regulatory mechanism through inhibition of T reg -cell responsiveness to IL-33, suggesting that the balance between IL-23 and IL-33 may be a major determinant of the outcome of intestinal immune responses.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. T cells were cultured with anti-CD3/CD28 plus TGF-b 1 , as well as the indicated cytokines, and the frequencies of Foxp3 1 T cells were determined 3 days later (mean 6 s.e.m. of three independent experiments). b, Naive CD4 1 T cells were cultured with anti-CD3/CD28 plus the indicated cytokines for 48 h. Data are from one experiment representative of two (mean 6 s.d.). c, Naive CD4 1 T cells were cultured as indicated. Representative blots of two independent experiments are shown. d, C57BL/6 Il23a 2/2 Rag1 2/2 mice were injected with CD45RB hi wild-type (WT; n 5 9) or St2 2/2 (n 5 10) T cells. Mice were killed 6-8 weeks after transfer and frequencies of Foxp3 1 CD4 1 T cells in colon are shown (mean 6 s.e.m.). e, Colitis scores for mice in d (mean 6 s.e.m.). f, Expression of the indicated cytokines by colonic CD4 1 T cells from mice in d (mean 6 s.e.m.). g, T reg cells were cultured with anti-CD3/CD28 for 24 h followed by stimulation with IL-33 in the presence or absence of IL-23.
Representative blots of two independent experiments are shown. h, T reg cells were cultured in the presence of anti-CD3/CD28 for 24 h and the mRNA expression of the indicated genes was measured after stimulation with IL-33 for 45 min in the presence or absence of IL-23 (mean 6 s.e.m. of three independent experiments). i, T reg cells were cultured with anti-CD3/CD28 for 24 h and representative blots of two independent experiments are shown. p, phosphorylated. *P , 0.05, **P , 0.01, ***P , 0.001 as calculated by one-way ANOVA with Bonferroni post-test or Student's t-test. NS, not significant.
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METHODS
Mice. Wild-type C57BL/6, congenic B6.SJL-Cd45.1, C57BL/6 Il23r 2/2 , C57BL/6 Rag1 2/2 , C57BL/6 Il23a 2/2 Rag1 2/2 and Foxp3 gfp reporter mice 31,32 were bred and maintained under specific pathogen-free conditions in accredited animal facilities at the University of Oxford. Where indicated, mice were intraperitoneally (i.p.) injected with recombinant IL-33 (1 mg per injection; Biolegend) for 5 consecutive days and killed 24 h after the last injection. Gata3 fl/fl -Foxp3-cre mice were kept at the National Institutes of Health (NIH) and experiments were performed at the NIH. Spleen, MLN and bone marrow from C57BL/6 St2 2/2 mice were obtained from P. Fallon or M. Loehning. All procedures were conducted in accordance with the UK Scientific Procedures Act of 1986. Mice were negative for Helicobacter spp. and other known intestinal pathogens, were age and sex-matched and more than 6 weeks old when first used. Both female and male mice were used in experiments. Wherever possible, preliminary experiments were performed to determine requirements for sample size, taking into account resources available and ethical, reductionist animal use. Generally, each mouse of the different experimental groups is reported. Exclusion criteria such as inadequate staining or low cell yield due to technical problems were pre-determined. Animals were assigned randomly to experimental groups. Each cage contained animals of all the different experimental groups.
Generation of mixed bone marrow chimaeras. Bone marrow isolated from wildtype (CD45.2 1 ), Il23r 2/2 or St2 2/2 mice was mixed at a 1:1 ratio with bone marrow taken from B6.SJL-Cd45.1 mice and injected intravenously into gamma-irradiated (5.5 Gy, 550 rad) C57BL/6 Rag1 2/2 recipients and chimaeras were used in experiments .8 weeks after injection. T-cell transfer colitis. For naive T-cell transfer colitis, 43 10 5 CD4 1 CD25 2 CD45 RB hi T cells were injected i.p. into Rag1 2/2 or Il23a 2/2 Rag1 2/2 recipients. In co-transfer experiments, 2 3 10 5 CD4 1 CD25 2 CD45 RB hi T cells from each source were mixed and injected i.p. into Rag1 2/2 hosts. For T reg -mediated protection from colitis, 4 3 10 5 CD4 1 CD25 2 CD45 RB hi T cells and 2 3 10 5 CD4 1 CD25 1 T reg cells were mixed and injected i.p. into Rag1 Histological assessment of intestinal inflammation. Proximal, mid, and distal colon samples were fixed in buffered 10% formalin solution. Paraffin-embedded sections were cut (5 mm) and stained with haematoxylin and eosin, and inflammation was scored in a blinded fashion using a previously described scoring system 29 .
Isolation of leukocyte subpopulations and flow cytometry. Cell suspensions from spleen, MLN, and the lamina propria were prepared as described previously 34 and first incubated with anti-CD16/CD32 (eBioscience) to prevent nonspecific binding. Single-cell suspensions were stained with antibodies against CD4, CD25, TCR-b, CD45.1, CD45.2, CD103, OX40, IL-17A, IFN-c, IL-13, Foxp3, GATA3, Helios (all from eBioscience), ROR-ct, Ki67 (BD Biosciences), CD45RB, KLRG1 (Biolegend) and anti-ST2 conjugated to biotin (mdBioproducts). Intracellular staining was performed as follows. Cells were restimulated for 4 h as previously described 35 , washed and incubated with anti-CD16/CD32. Cells were washed and stained for surface markers as indicated earlier and fixed in eBioscience Fix/Perm buffer, followed by permeabilization in eBioscience permeabilization buffer for 1 h in the presence of antibodies. Cells were acquired with a BD LSRII and analysis was performed with FlowJo (Tree Star) software. T reg -cell cultures. CD25 2 CD62L 1 CD44 lo GFP 2 naive CD4 1 T cells were sortpurified from Foxp3 gfp reporter mice. Cells were plated at 2 3 10 5 cells per well in flat-bottomed 96-well plates coated with anti-CD3 (5 mg ml 21 ) in RPMI (Invitrogen) containing 10% FCS, 2 mM L-glutamine, 0.05 mM 2-mercaptoethanol, and 100 U ml 21 each of penicillin and streptomycin (complete media). Antibodies and cytokines were added at the following concentrations: anti-CD28 (2 mg ml 21 ), TGFb 1 (R&D; 500 pg ml 21 ), IL-2 (Peprotech; 1 U ml 21 ), IL-23 (R&D; 20 ng ml 21 ), IL-33 (Biolegend; 1 ng ml 21 ). Cells were harvested at indicated times, lysed for use for qPCR, western blot or analysed by flow cytometry. GFP 1 CD4 1 T reg cells were sort-purified from Foxp3 gfp reporter mice and cells were plated at 2 3 10 5 cells per well in flatbottomed 96-well plates coated with anti-CD3 (5 mg ml 21 ) in complete media and anti-CD28 (2 mg ml 21 ), IL-2 (Peprotech; 1 U ml 21 ) or IL-33 (Biolegend; 1 ng ml 21 ) were added at the start of the culture. Cells were analysed after 3 days by flow cytometry. For acute stimulation, 2 3 10 5 cells per well were plated in 96-well plates coated with anti-CD3 (5 mg ml 21 ) in complete media and soluble anti-CD28 (2 mg ml 21 ) and cultured for 24 h. Cells were then stimulated with IL-33 (10 ng ml 21 ) for the indicated time and used for qPCR or western blot.
T reg -cell suppression assay. CD25 1 CD4 1 T reg cells were sorted by flow cytometry from wild-type and St2 2/2 mice. CD25 2 CD62L 1 CD44 2 CD4 1 T cells (responder cells) were sorted from St2 2/2 mice. Antigen presenting cells (APCs) were isolated by magnetic bead separation from splenocytes and lymph node cells from St2 2/2 mice. T responder cells were labelled with Violet cell trace and plated together with the sorted T reg cells at ratios of 1:1 and 1:3 together with irradiated APCs in the presence of anti-CD3 (1 mg ml 21 ). IL-33 was added at 30 ng ml 21 . After 4 days proliferation of T responder cells was measured by flow cytometry. Colon explant cultures. Organ explants were prepared as previously described 35 and cultured overnight in complete media. Cytokine levels in the supernatants were determined by enzyme-linked immunosorbent assay (ELISA) IL-23 and IL-33 (eBioscience) and soluble ST2 (R&D), and concentrations were normalized to the weight of the explants. Isolation and culture of colonic stromal cells. Colonic tissue was digested and cells from the 30:40% Percoll gradient interface were harvested and washed twice in PBS containing 2% BSA. Cells were plated at 10 3 10 6 cells ml 21 in complete DMEM containing 40 mg ml 21 gentamycin (Sigma). After 24-48 h, non-adherent cells were removed by vigorous washing, and media replaced. Adherent intestinal stromal cells were cultured for 10 days until confluent. Cells were then plated at 1 3 10 6 cells ml 21 for 48 h and the concentration of soluble ST2 in supernatants was determined by ELISA (R&D Systems). qPCR and microarray preparation. RNA was extracted according to the manufacturers' protocol (RNeasy, Qiagen) and complementary DNA synthesis was performed using Superscript III reverse transcription and Oligo dT primers (both from Invitrogen). qPCR reactions were performed using TaqMan Gene Expression Assays and normalized to HPRT (all from Applied Biosystems). Alternatively, qPCR reactions were performed using SYBR green PCR SensiMix (Quantace) with previously described primers 16 . For soluble ST2 the following primers were used: soluble ST2 forward 59-TCGAAATGAAAGTTCCAGCA-39 and soluble ST2 reverse 59-TGTGTGAGGGACACTCCTTAC-39. Samples were assayed in duplicate on a Bio-Rad CFX96 RT-qPCR machine and differences were calculated using the 2 DCt method.
For microarray gene expression analysis, RNA was extracted using the RNAqueous-Micro Total RNA Isolation Kit or RiboPure RNA Purification Kit (both Ambion). For RNA amplification and labelling the TargetAmp2-Round Biotin-aRNA Amplification Kit 3.0 (Epicentre, Illumina) or the Illumina TotalPrep RNA Amplification Kit (Ambion) were used and RNA quality was assessed using the Agilent 2100 Bioanalyzer and only samples with RNA integrity number (RIN) values above 7 were used for further processing. Biotinylated cRNA was hybridized to MouseWG-6 v.2.0 Expression BeadChip (Illumina). Hybridizations to BeadChips and data acquisition were performed by the microarray core facility at the Wellcome Trust Center for Human Genetics, Oxford. Microarray analysis was performed using GeneSpring GX12 software (Agilent). Data were normalized using 75% percentile shift normalization algorithm and baseline transformed to the median of all samples. Statistical significance was determined using an unpaired t-test followed by Benjamini-Hochberg false discovery rate multiple testing correction. P value cutoff was set to 0.05. Total protein extracts and immunoblot analysis. Total protein extracts were prepared as described 36 . Equal amounts of protein were resolved by SDS-PAGE and analysed with anti-pGATA3 (ab61052; Abcam), anti-total GATA3 (L50-823; BD Pharmingen), anti-ST2 (101001B; mdBioproducts), anti-actin (A5541; Sigma) or anti-IL-33 (396118, R&D). For inhibition of STAT3 activity in vitro, STAT3 VI (10 mM; Santa Cruz) was added 30 min before cytokine stimulation. ChIP. ChIP assays were performed as described 36 with antibody to GATA3 (L50-823; BD Pharmingen) or RNA polymerase II (sc-899; Santa Cruz). The immunoprecipitated DNA fragments were then analysed by real-time PCR with SYBR Premix Ex TaqII master mix (Takara Bio) and the following primers: locus encoding St2 enhancer, 59-GCCAACCACAACAGCAGATGGGGAAA-39 and 59-ACTGAGATCCTG CCTGGCTTCCCT-39; locus encoding St2 promoter, 59-TGGCCTCCTTGGAAAG GCTTGGT-39 and 59-AGTGCAGGAGGGGCATGGAGATGA-39. Primers for analysing binding to CNS1, CNS2, CNS3 and the promoter locus of Foxp3 were as described previously 25 . Data were analysed using Vii7A qPCR software (Applied Biosystems). Results are normalized to input DNA and presented as fold enrichment relative to unstimulated cells. Statistical analysis. Where appropriate, Student's t-test was used. For the comparison of more than two groups a one-way ANOVA followed by a Bonferroni multiple comparison test was performed. All statistical analysis was calculated in Prism (GraphPad). Differences were considered to be statistically significant when P # 0.05. 
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